What Are the Challenges in Nanotechnology-based Drug Release?
Despite its potential, nanotechnology-based drug release faces several challenges:
- Biocompatibility: Ensuring that nanocarriers are non-toxic and do not provoke an immune response is crucial. - Scalability: Producing nanocarriers on a large scale while maintaining consistency and quality can be difficult. - Regulatory Approval: Navigating the regulatory landscape for new nanotechnology-based therapies is complex and time-consuming. - Cost: The development and production of nanocarriers can be expensive, potentially limiting accessibility.
